Exscientia Aktie - EXAI

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Current Price

4,84

Gebot

5,61

Fragen

4,55

Volumen

0,00 Tagesbereich 0,00

0,00 52-Wochen-Bereich 0,00

Handelsende

4,84

Handelsbeginn

Letzte Trade

Letzter Handelszeitpunkt

Durchschnittliches Volumen (3 Mio.)

Finanzvolumen

VWAP

Form 15-12G - Securities registration termination [Section 12(g)]

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programsPlatform...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

EXAI - Frequently Asked Questions (FAQ)

What is the current Exscientia share price?

The current share price of Exscientia is US$ 4,84

What is the 1 year trading range for Exscientia share price?

Exscientia has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
VRMEVerifyMe Inc	US$ 2,57 (52,98%)	57,83M
WKEYWISeKey International Holdings AG	US$ 10,041 (52,83%)	6,72M
DATSDatChat Inc	US$ 4,8105 (49,86%)	158,65M
CDTConduit Pharmaceuticals Inc	US$ 0,1214 (48,05%)	1,17B
INTZIntrusion Inc	US$ 2,8888 (44,44%)	40,61M
IGMSIGM Biosciences Inc	US$ 2,095 (-66,21%)	5,69M
CDTGCDT Environmental Technology Investment Holdings Ltd	US$ 1,87 (-51,30%)	2,28M
MODVModivCare Inc	US$ 6,51 (-47,88%)	2,73M
AIFUAIX Inc	US$ 0,420501 (-47,76%)	7,83M
MRSNMersana Therapeutics Inc	US$ 0,691 (-46,85%)	58,31M
CDTConduit Pharmaceuticals Inc	US$ 0,1214 (48,05%)	1,17B
NVDANVIDIA Corporation	US$ 135,91 (-3,00%)	207,53M
RGTIRigetti Computing Inc	US$ 8,9299 (-11,06%)	178,82M
VMARVision Marine Technologies Inc	US$ 2,14 (40,79%)	175,57M
DATSDatChat Inc	US$ 4,8105 (49,86%)	158,65M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Exscientia PLC (EXAI)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

EXAI Neueste Nachrichten

Form 15-12G - Securities registration termination [Section 12(g)]

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 15-12G - Securities registration termination [Section 12(g)]

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

EXAI - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Exscientia PLC (EXAI) Börsenkurse

Exscientia PLC (EXAI)

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

EXAI Neueste Nachrichten

EXAI - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR